Business Description
Nova Eye Medical Ltd
ISIN : AU0000094252
Description
Nova Eye Medical Ltd is a medical technology company that develops, manufactures and sells a portfolio of proprietary ophthalmic treatment technologies and devices. Used by eye surgeons globally, these technologies include iTrack minimally invasive glaucoma surgery (MIGS), a consumable surgical device that restores the eye's natural outflow pathway to lower pressure inside the eye and to eliminate patient reliance on anti-glaucoma medications for mild-moderate glaucoma. The company's operating segment include AlphaRET and Glaucoma Surgical Devices, it generates maximum revenue from Glaucoma Surgical Devices. Geographically, it derives a majority of revenue from the United States of America.
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 2.15 | |||||
Equity-to-Asset | 0.71 | |||||
Debt-to-Equity | 0.07 | |||||
Debt-to-EBITDA | -0.15 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 3.11 | |||||
Beneish M-Score | -3.06 | |||||
WACC vs ROIC |
Growth Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 6.8 | |||||
3-Year EBITDA Growth Rate | -16.1 | |||||
3-Year EPS without NRI Growth Rate | 4 | |||||
3-Year Book Growth Rate | -44.1 | |||||
Future 3-5Y EPS without NRI Growth Rate | 52.32 | |||||
Future 3-5Y Total Revenue Growth Rate | 31.62 |
Momentum Rank
7/10
Name | Current | Vs Industry | Vs History |
---|
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.47 | |||||
Quick Ratio | 0.81 | |||||
Cash Ratio | 0.42 | |||||
Days Inventory | 757.21 | |||||
Days Sales Outstanding | 41.56 | |||||
Days Payable | 727.41 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -9.8 | |||||
Shareholder Yield % | 0.84 |
Profitability Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 90.24 | |||||
Operating Margin % | -55.2 | |||||
Net Margin % | -76.24 | |||||
FCF Margin % | -37.08 | |||||
ROE % | -66 | |||||
ROA % | -50.34 | |||||
ROIC % | -46.27 | |||||
ROC (Joel Greenblatt) % | -94.02 | |||||
ROCE % | -46.31 | |||||
Years of Profitability over Past 10-Year | 4 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shiller PE Ratio | 41.98 | |||||
PS Ratio | 2.57 | |||||
PB Ratio | 3.05 | |||||
Price-to-Tangible-Book | 5 | |||||
EV-to-EBIT | -5.59 | |||||
EV-to-EBITDA | -7.41 | |||||
EV-to-Revenue | 3.16 | |||||
EV-to-FCF | -8.51 | |||||
Price-to-Median-PS-Value | 1.67 | |||||
Earnings Yield (Greenblatt) % | -17.89 | |||||
FCF Yield % | -11.48 | |||||
Forward Rate of Return (Yacktman) % | -12.05 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:ELXMF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Nova Eye Medical Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 12.581 | ||
EPS (TTM) ($) | -0.054 | ||
Beta | -355.56 | ||
Volatility % | 0 | ||
14-Day RSI | 0 | ||
14-Day ATR ($) | 0 | ||
20-Day SMA ($) | 0.1 | ||
12-1 Month Momentum % | 0 | ||
52-Week Range ($) | 0.1 - 0.1 | ||
Shares Outstanding (Mil) | 228.82 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Nova Eye Medical Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Nova Eye Medical Ltd Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Nova Eye Medical Ltd Frequently Asked Questions
What is Nova Eye Medical Ltd(ELXMF)'s stock price today?
The current price of ELXMF is $0.10. The 52 week high of ELXMF is $0.10 and 52 week low is $0.10.
When is next earnings date of Nova Eye Medical Ltd(ELXMF)?
The next earnings date of Nova Eye Medical Ltd(ELXMF) is .
Does Nova Eye Medical Ltd(ELXMF) pay dividends? If so, how much?
Nova Eye Medical Ltd(ELXMF) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |